Inhibitor Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Inhibitor Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2012 to Q3 2024.
  • Inhibitor Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 172M shares, a 0.17% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 172M +300K +0.17% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 172M +355K +0.21% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 172M +530K +0.31% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 172M +230K +0.13% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 172M -205M -54.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 172M -205M -54.4% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 172M -205M -54.4% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 172M -205M -54.4% Dec 31, 2022 10-K 2024-03-29
Q3 2022 377M +982K +0.26% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 377M +982K +0.26% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 377M +982K +0.26% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 377M +3.22M +0.86% Dec 31, 2021 10-K 2023-03-31
Q3 2021 376M +2.24M +0.6% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 376M +5.43M +1.47% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 376M +5.43M +1.47% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 374M +3.19M +0.86% Dec 31, 2020 10-K 2022-03-30
Q3 2020 374M +3.19M +0.86% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 370M 0 0% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 370M 0 0% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 370M +362K +0.1% Dec 31, 2019 10-K 2021-03-26
Q3 2019 370M +487K +0.13% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 370M +847K +0.23% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 370M +772K +0.21% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 370M +485K +0.13% Dec 31, 2018 10-K 2020-03-30
Q3 2018 370M +360K +0.1% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 370M 0 0% Jun 30, 2018 10-Q 2018-07-23
Q1 2018 370M +488K +0.13% Mar 31, 2018 10-Q 2018-05-01
Q4 2017 370M +16.2M +4.57% Dec 31, 2017 10-K 2019-03-07
Q3 2017 370M +69.2M +23.1% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 370M +69.2M +23.1% Jun 30, 2017 10-Q 2017-07-31
Q1 2017 369M +124M +50.5% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 353M +108M +44.1% Dec 31, 2016 10-K 2018-02-16
Q3 2016 300M +55M +22.4% Sep 30, 2016 10-Q 2016-10-31
Q2 2016 300M +55M +22.4% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 245M +33.9M +16.1% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 245M +33.9M +16.1% Dec 31, 2015 10-K 2017-02-17
Q3 2015 245M +33.9M +16.1% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 245M +204M +492% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 211M +193M +1019% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 211M +193M +1019% Dec 31, 2014 10-K 2016-02-01
Q3 2014 211M +193M +1019% Sep 30, 2014 10-Q 2014-10-10
Q2 2014 41.4M Jun 30, 2014 10-Q 2014-08-13
Q1 2014 18.9M Mar 31, 2014 10-Q 2014-05-12
Q4 2013 18.9M +3.33M +21.4% Dec 31, 2013 10-K 2015-02-13
Q3 2013 18.9M Sep 30, 2013 10-Q 2013-11-14
Q4 2012 15.6M Dec 31, 2012 10-K 2014-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.